{"type":"video","version":"1.0","html":"<iframe src=\"https://www.loom.com/embed/26d41a370977441ba6567939707d9827\" frameborder=\"0\" width=\"1920\" height=\"1440\" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>","height":1440,"width":1920,"provider_name":"Loom","provider_url":"https://www.loom.com","thumbnail_height":1440,"thumbnail_width":1920,"thumbnail_url":"https://cdn.loom.com/sessions/thumbnails/26d41a370977441ba6567939707d9827-8bb1093bc989dd0f.gif","duration":2170.735,"title":"Exploring Babesia: Advances in Diagnosis and Treatment of Tick-Borne Infections 🦠","description":"In this presentation, I discussed our research on Babesia parasites, particularly Babesia microti and Babesia duncani, which are significant human pathogens transmitted by ticks. We have sequenced their genomes, revealing unique features that could aid in developing diagnostics and therapies. I highlighted our findings on how these parasites communicate with their host and the promising results of our drug combination therapy involving Tafinokwin and Atovakone, which shows potential for treating both Babesia and malaria. I encourage you to consider the implications of our findings for future research and clinical applications, and I welcome any questions you may have."}